StockData
Stereotaxis, Inc. logo

Stereotaxis, Inc. (STXS) stock

STXSNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/3018% below fair value
$0.88+0.08 (+9.89%)

Close on Nov 17, 2026Market cap $88.39MP/E –Yield –

Stereotaxis total assets

Total assets on the balance sheet at the end of each period.

Stereotaxis's total assets was $55.58M at Jun 30, 2026. For fiscal 2025 it was $52.25M, up 11.8% from the year before. Over ten years it grew 10.7% a year on average. The highest annual figure on record is $65.76M in fiscal 2010.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$52.25M+11.8%
FY2024Dec 31, 2024$46.72M+11.5%
FY2023Dec 31, 2023$41.91M-21.5%
FY2022Dec 31, 2022$53.41M-12.4%
FY2021Dec 31, 2021$60.99M+10.0%
FY2020Dec 31, 2020$55.46M+27.2%
FY2019Dec 31, 2019$43.58M+135.4%
FY2018Dec 31, 2018$18.51M+73.6%
FY2017Dec 31, 2017$10.67M-49.1%
FY2016Dec 31, 2016$20.97M+11.1%
FY2015Dec 31, 2015$18.88M-20.9%
FY2014Dec 31, 2014$23.88M-23.2%
FY2013Dec 31, 2013$31.08M-3.4%
FY2012Dec 31, 2012$32.17M-19.4%
FY2011Dec 31, 2011$39.93M-39.3%
FY2010Dec 31, 2010$65.76M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$55.58M+35.0%
Q1 FY2026Mar 31, 2026$54.03M+18.2%
Q4 FY2025Dec 31, 2025$52.25M+11.8%
Q3 FY2025Sep 30, 2025$45.59M-10.5%
Q2 FY2025Jun 30, 2025$41.17M+14.3%
Q1 FY2025Mar 31, 2025$45.71M+15.8%
Q4 FY2024Dec 31, 2024$46.72M+11.5%
Q3 FY2024Sep 30, 2024$50.94M+14.4%
Q2 FY2024Jun 30, 2024$36.01M-25.5%
Q1 FY2024Mar 31, 2024$39.45M-22.2%
Q4 FY2023Dec 31, 2023$41.91M-21.5%
Q3 FY2023Sep 30, 2023$44.53M-20.6%
Q2 FY2023Jun 30, 2023$48.32M-14.8%
Q1 FY2023Mar 31, 2023$50.71M-11.7%
Q4 FY2022Dec 31, 2022$53.41M-12.4%
Q3 FY2022Sep 30, 2022$56.08M-9.4%
Q2 FY2022Jun 30, 2022$56.68M-1.1%
Q1 FY2022Mar 31, 2022$57.43M-2.4%
Q4 FY2021Dec 31, 2021$60.99M+10.0%
Q3 FY2021Sep 30, 2021$61.92M+8.4%
Q2 FY2021Jun 30, 2021$57.34M+0.5%
Q1 FY2021Mar 31, 2021$58.82M+41.7%
Q4 FY2020Dec 31, 2020$55.46M+27.2%
Q3 FY2020Sep 30, 2020$57.13M+31.9%
Q2 FY2020Jun 30, 2020$57.05M+168.4%
Q1 FY2020Mar 31, 2020$41.50M+84.9%
Q4 FY2019Dec 31, 2019$43.58M+135.4%
Q3 FY2019Sep 30, 2019$43.31M+120.7%
Q2 FY2019Jun 30, 2019$21.26M+6.4%
Q1 FY2019Mar 31, 2019$22.44M+5.2%
Q4 FY2018Dec 31, 2018$18.51M+73.6%
Q3 FY2018Sep 30, 2018$19.62M+29.7%
Q2 FY2018Jun 30, 2018$19.97M+19.7%
Q1 FY2018Mar 31, 2018$21.33M+12.3%
Q4 FY2017Dec 31, 2017$10.67M-49.1%
Q3 FY2017Sep 30, 2017$15.13M-30.0%
Q2 FY2017Jun 30, 2017$16.68M–
Q1 FY2017Mar 31, 2017$18.99M–
Q4 FY2016Dec 31, 2016$20.97M–
Q3 FY2016Sep 30, 2016$21.60M–

More Stereotaxis figures

See a number that looks wrong?